0001209191-22-017592.txt : 20220309 0001209191-22-017592.hdr.sgml : 20220309 20220309163331 ACCESSION NUMBER: 0001209191-22-017592 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220110 FILED AS OF DATE: 20220309 DATE AS OF CHANGE: 20220309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bandari Jathin CENTRAL INDEX KEY: 0001903622 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 22725814 MAIL ADDRESS: STREET 1: C/O PROTORA THERAPEUTICS, INC. STREET 2: 345 PARK AVENUE SOUTH, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 204580525 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: ArTara Therapeutics, Inc. DATE OF NAME CHANGE: 20200110 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-01-10 2022-01-12 0 0001359931 Protara Therapeutics, Inc. TARA 0001903622 Bandari Jathin C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR NEW YORK NY 10010 0 1 0 0 Chief Medical Officer Common Stock 21000 D On January 12, 2022, the Reporting Person filed a Form 4 which inadvertently reported that, following the issuance of a restricted stock unit award, he directly owned 13,500 shares of the Issuer's common stock. In fact, as reported in this amendment, the Reporting Person directly owned 21,000 shares of common stock. /s/ Mary Grendell, Attorney-in-Fact 2022-03-09